TrialAlzheimer's & dementia : the journal of the Alzheimer's Association2021

Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.

Nicholas J Izzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.